Dotmatics Limited, a leading provider of drug discovery informatics solutions and services, is pleased to announce the addition of Dr. Mariana Vaschetto to their Business Development Team. Dr. Vaschetto will serve as Vice President of Business Development and Marketing for Europe, Middle East, Africa and Latin America and will strengthen the growth and expansion of the Dotmatics software and technology platform within the EMEA as well as Asian and

Latin-American markets.

Dr. Vaschetto brings more than thirteen years of experience in the science and technology market. She is a respected leader in international marketing and business development in life science informatics having held increasingly senior scientific marketing and sales roles at Accelrys, Genelogics and CambridgeSoft (Now PerkinElmer). She brings to Dotmatics a

strong brand-building background and a successful track record on delivering desktop as well as enterprise informatics solutions. With this appointment Dotmatics is looking to cement its position as the preferred partner for the pharmaceutical, biotech, chemicals and academic industries. In addition, Dr Vaschetto brings extensive knowledge of emerging markets, thus enabling Dotmatics to expand into new territories.

“We are delighted to have Dr. Vaschetto in our team to ensure the successful positioning of our solutions as well as our market penetration into new emerging territories” commented Dr Stephen Gallagher, Dotmatics’ Chief Executive Officer. “Dr Vaschetto brings solid technology market expertise as well as deep knowledge of the industry. She will play a

significant role in the company’s growth” he added.

“Joining Dotmatics was a very easy decision. Their state-of-the-art informatics solutions coupled with world-class services make Dotmatics a very exciting company” commented Dr. Mariana Vaschetto. “Dotmatics’ data management, query and analysis solutions are modern, user-friendly, easy to deploy and they capture perfectly the drug discovery and development process. It is very exciting to play a role in the expansion and penetration of this new technology into existing and new markets.”